Hot Deals:
adtech 29.10 (0.34 %) agarwal bolts 1,200.00 (0.00 %) amol minechem 525.00 (1.94 %) anand i-power 20.00 anglo french drugs 745.00 (-0.67 %) apl metals 40.00 (-4.78 %) arkfin investments 50.00 arohan 125.00 (3.31 %) assam carbon 200.00 (2.56 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) av thomas 16,750.00 (1.18 %) axles 220.00 (-2.22 %) balmer lawrie 199.00 (1.02 %) bharat hotels 200.00 (-2.44 %) bima mandi 700.00 bira 600.00 (1.69 %) boat 890.00 (-1.11 %) c & s electric 550.00 (0.92 %) cable corporation 12.10 (0.83 %) capgemini 11,111.00 (1.01 %) care health 171.00 (-0.58 %) carrier aircon 290.00 (-3.33 %) cial 189.00 (1.07 %) csfbl 370.00 (-1.33 %) csk 163.00 (-1.21 %) dalmia refract 145.00 (-2.03 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 425.00 (2.66 %) electronica plastic 4,100.00 (-0.24 %) elgi ultra 400.00 elofic 2,100.00 (2.44 %) esl steel 23.00 (0.44 %) fincare business 45.50 (1.11 %) fincare sfbl 136.00 (-2.86 %) finopaytech 139.00 (-0.71 %) flipkart india 231,001.00 (0.00 %) frick india 7,100.00 (2.90 %) gkn driveline 1,250.00 (4.17 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdb financial 655.00 (-0.76 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,800.00 (-0.92 %) hella india 810.00 (1.25 %) hero fincorp 1,160.00 (-1.69 %) hexaware 600.00 (1.69 %) hicks 1,450.00 (2.11 %) hira ferro 150.00 (0.67 %) honeywell electrical 3,600.00 (-0.28 %) ikf finance 221.00 (0.45 %) incred financial 100.00 india carbon 900.00 (-1.10 %) india exposition 135.00 (-0.74 %) indian potash 1,300.00 (-0.38 %) indo alusys 25.75 (-0.96 %) indofil 640.00 (-2.29 %) infinite computer 405.00 (1.25 %) inkel 12.00 (-1.64 %) ixigo 96.00 (5.49 %) jana small finance bank 75.00 kel 510.00 (-1.92 %) kial 97.00 (1.04 %) klm axiva 16.20 (0.62 %) kurlon limited 490.00 (-2.00 %) lava 93.00 (-2.11 %) manipal housing 72.50 (0.69 %) manjushree technopack 1,010.00 (1.00 %) martin & harris 1,125.00 (4.17 %) merino 3,030.00 (-2.26 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 405.00 (-3.57 %) mobikwik 315.00 (-1.56 %) mohan meakin 1,640.00 (0.92 %) mohfl 9.25 (-0.54 %) mrhfl 100.00 msei 0.86 (-2.27 %) msil 41.00 (-8.89 %) nayara energy 250.00 (-1.96 %) nayara energy ncd 255.00 (-1.92 %) ncdex 275.00 ncl buildtek 195.00 (-2.99 %) ncl holdings 60.00 (1.69 %) nsdl 700.00 nse 3,350.00 (0.90 %) orbis financial 117.00 (1.74 %) oswal minerals 60.10 (-1.48 %) otis 3,900.00 (4.00 %) oyo 73.00 (1.39 %) panasonic appliances 202.00 (1.00 %) panasonic avc 29.00 (-0.34 %) paymate india 360.00 (2.86 %) pharmeasy 9.50 (1.06 %) philips domestic 560.00 (-1.75 %) philips india 875.00 (2.94 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 320.00 (1.59 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 405.00 (1.25 %) resins plastics 415.00 (-1.89 %) ring plus aqua 405.00 (0.25 %) rrl 1,275.00 (2.00 %) sab miller 365.00 (-3.69 %) sbi amc 1,075.00 (1.90 %) sbi general insurance 569.00 scottish assam 446.00 (0.68 %) shriram life 261.00 (0.38 %) sigachi laboratories 39.00 (-2.74 %) signify 1,510.00 (0.67 %) smile microfinance 54.00 (3.85 %) sportskeeda 3,303.00 sterlite power 520.00 (1.96 %) studds 830.00 (-0.60 %) svsml 333.00 (-4.86 %) swiggy 361.00 (0.28 %) t stanes 770.00 (2.67 %) tata capital 445.00 (2.30 %) tata tech 930.00 (1.09 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,200.00 (1.69 %) utkarsh coreinvest 190.00 (2.70 %) vadilal dairy 10.00 vikram solar 350.00 (2.94 %) waree energies 800.00 (3.90 %) zylog 0.01 (-0.99 %)
×

Martin & Harris Unlisted Share Price

Company Name
Martin And Harris Laboratories Limited
Scrip Name
Martin & Harris
Last Traded Price
1,125.00
+ 4.17 %
Sector
Pharma
PAN No.
AABCM0832A
Face Value
10
No. of Outstanding Shares
3,996,040
EPS
442.598
PE ratio
2.542
Market Capitalization
449.55 Crore
Book value
1115.133
P/BV
1.0088
ISIN No.
INE03VV01015
Available on
nsdl
ROFR Require
No

Martin and Harris Laboratories Limited Unlisted Share – Company Overview

MARTIN AND HARRIS LABORATORIES LIMITED was first established in 1996 and is based in Gurgaon, Haryana. The company is a part of Apeejay Group, which is India’s oldest and largest Conglomerates. Apeejay Group is a leading Industrial & Investment house with businesses in Automotive, Chemicals & Plastics, Distribution, Logistics & Retail, Pharmaceuticals & life sciences, real estate, and international trading and a nascent presence in IT, merchant banking & financial services and publishing.

Martin and Harris Laboratories Limited is primarily engaged in the business of manufacturing pharmaceuticals, medicinal chemicals & botanical products. The company intensively focuses on drugs used for Hyper Tension, High blood pressure, and heart attack. Apart from its primary business, the company also undertakes fund management through investment in different avenues like mutual funds, equity, etc.

Martin and Harris Laboratories Limited has two units located at Roorkee, Uttarakhand, and Una in Himachal Pradesh. The company is continuously striving to expand its manufacturing facilities and meet global standards.

The company was awarded ‘Best Pharma Excellence awards’ in 2018 by ASSOCHAM India.

Martin And Harris Laboratories Limited Incorporation Details

CIN of Martin and Harris Laboratories

U24239HR1993PLC033630

Registration Date of Martin and Harris Laboratories

22 July 1993

Category/Sub-category of Martin and Harris Laboratories

Company Limited by Shares

Martin and Harris Laboratories Registered office address 

NH-8, Delhi Jaipur Highway,

Village, Pachgaon (Fazalwas),

District Gurgaon, Haryana

Martin and Harris Laboratories Registrar and Transfer Agent address and contact details

NA

Martin And Harris Laboratories Limited Principal Business Activities

Name and Description of main products/services

NIC Code of the product/service

% to total turnover of the Company

Manufacture of Pharmaceutical, Medicinal Chemical & Botanical Products

210

52.03%

Fund management activities

663

47.97%

Martin And Harris Laboratories Limited Board of Directors

MR. S. L. LAAD

MR. G. K. NIGAM

MR. AJAY GROVER

MR. H. S. THAKUR

Martin And Harris Laboratories Particular of Subsidiary Companies

Name of the Company

% of shares held

Delite Infrastructure Private limited

100.00%

Martin And Harris Laboratories Limited Shareholding Pattern (As on 31-03-2020)

S. No.

Shareholders’ Name

Number of shares

% of total Shares of the company

1

Promoters Shareholding

140

0.004%

2

Public Shareholding

39,95,900

99.996%

 

Total

39,96,040

100.00%

Industry Outlook

 Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability has helped India to manufacture pharma products at a very low cost.

The Indian healthcare market may see a 3 fold jump in terms of value to reach US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.

Export of Pharmaceuticals products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat the covid patients in the initial stage of the covid-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.

After the onset of COVID 19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

Annual Report

Martin And Harris Annual Report 2019-20

Download

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha